Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Mark G, Midei"'
Autor:
Plamena R. Angelova, Kristin M. Andruska, Mark G. Midei, Mario Barilani, Paldeep Atwal, Oliver Tucher, Peter Milner, Frederic Heerinckx, Mikhail S. Shchepinov
Publikováno v:
Antioxidants, Vol 10, Iss 7, p 1021 (2021)
Progressive supranuclear palsy (PSP) is a progressive movement disorder associated with lipid peroxidation and intracerebral accumulation of tau. RT001 is a deuterium reinforced isotopologue of linoleic acid that prevents lipid peroxidation (LPO) thr
Externí odkaz:
https://doaj.org/article/e8659cfd4ff74cf387d8f09a350c6e5a
Autor:
Megan Yerton, Allison Winter, Anthony Kostov, Cassandra Lieberman, Dario Gelevski, Harli Weber, Michael Doyle, Geli Kane, Neil Parikh, Katherine M. Burke, Margot Rohrer, Taylor Stirrat, Margaret Bruno, Alison Hochman, Sarah Luppino, Jennifer Scalia, Debra Skoniecki, Derek D'Agostino, Ervin Sinani, Hong Yu, Alexander V. Sherman, Suma Babu, James D. Berry, Mark G. Midei, Peter G. Milner, Merit E. Cudkowicz, Sabrina Paganoni
Publikováno v:
Musclenerve. 66(4)
Lipid peroxidation is thought to play a biologically important role in motor neuron death in amyotrophic lateral sclerosis (ALS). 11,11 Di-deuterated linoleic ethyl ester (RT001) prevents lipid peroxidation in cellular and mitochondrial membranes. He
Autor:
Mark G. Midei, Lex van der Ploeg, Mikhail S. Shchepinov, Paldeep S. Atwal, Frederic Heerinckx, Peter Milner, Karsten Schmidt, Genevieve James, Robert Fielding, J. Thomas Brenna
Publikováno v:
Journal of Pharmaceutical Sciences. 109:3496-3503
RT001 is the di-deutero isotopologue of linoleic acid ethyl ester (D2-LA). Resistance to oxidative damage at the carbon-deuterium bond depends upon the concentration of D2-LA as a percentage of total LA. We report here on the plasma and red cell (RBC
Autor:
Mark G. Midei, Paldeep S. Atwal, Mario Barilani, Kristin M. Andruska, Oliver Tucher, Plamena R. Angelova, Frederic Heerinckx, Mikhail S. Shchepinov, Peter Milner
Publikováno v:
Antioxidants
Volume 10
Issue 7
Antioxidants, Vol 10, Iss 1021, p 1021 (2021)
Volume 10
Issue 7
Antioxidants, Vol 10, Iss 1021, p 1021 (2021)
Background: Progressive supranuclear palsy (PSP) is a progressive movement disorder associated with lipid peroxidation and intracerebral accumulation of tau. RT001 is a deuterium reinforced isotopologue of linoleic acid that prevents lipid peroxidati
Autor:
Greg Ayers, Jean-Philippe Couderc, Randy Brown, Philip T. Sager, Mark G. Midei, William Daly, A. John Camm, Georg Ferber, Borje Darpo
Publikováno v:
Journal of clinical pharmacologyReferences. 61(12)
Perhexiline has been used to treat hypertrophic cardiomyopathy. In addition to its effect on carnitine-palmitoyltransferase-1, it has mixed ion channel effects through inhibition of several cardiac ion currents. Effects on cardiac ion channels expres
Autor:
Darius J. Adams, Peter G. Milner, Frederic Heerinckx, Mark G. Midei, Paldeep S. Atwal, Alex J. Fay
Publikováno v:
Orphanet journal of rare diseases, vol 15, iss 1
Orphanet Journal of Rare Diseases, Vol 15, Iss 1, Pp 1-9 (2020)
Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases, Vol 15, Iss 1, Pp 1-9 (2020)
Orphanet Journal of Rare Diseases
Background INAD is an autosomal recessive neurogenetic disorder caused by biallelic pathogenic variants in PLA2G6. The downstream enzyme, iPLA2, plays a critical role in cell membrane homeostasis by helping to regulate levels of phospholipids. The cl
Autor:
Fowzan S. Alkuraya, Peter Milner, Paldeep S. Atwal, Fadie D. Altuame, Mark G. Midei, Mohammad A. Al-Muhaizea, Gretchen Kissel Foskett, Mais Hashem, Sarah Endemann, Muddathir H. Hamad, Mustafa A. Salih
Publikováno v:
Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases, Vol 15, Iss 1, Pp 1-12 (2020)
Orphanet Journal of Rare Diseases, Vol 15, Iss 1, Pp 1-12 (2020)
Background Infantile neuroaxonal dystrophy (INAD) is a rapidly progressive neurodegenerative disorder of early onset causing premature death. It results from biallelic pathogenic variants in PLA2G6, which encodes a calcium-independent phospholipase A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::154b04703e7353be85f4597d78252433
https://doi.org/10.21203/rs.2.19797/v2
https://doi.org/10.21203/rs.2.19797/v2
Publikováno v:
Trends in molecular medicine. 26(4)
Pharmacokinetics and pharmacodynamics of tecarfarin, a novel vitamin K antagonist oral anticoagulant
Autor:
David J. Ellis, Mark G. Midei, Daniel M. Canafax, Daniel Combs, Detlef Albrecht, Pascal Druzgala, Peter G. Milner
Publikováno v:
Thrombosis and Haemostasis. 117:706-717
SummaryTecarfarin is a vitamin K antagonist (VKA) with reduced propensity for drug interactions. To evaluate the pharmacokinetic (PK), pharmacodynamic (PD), and safety of tecarfarin, we performed single ascending dose (SAD) (n=66), multiple ascending
Autor:
Mikhail S. Shchepinov, Peter G. Milner, Christina Flora, Robert J. Molinari, Darius J. Adams, Mark G. Midei, Frederic Heerinckx, Paldeep S. Atwal, Sarah Endemann, Jahannaz Dastgir
Publikováno v:
JIMD Reports
JIMD Reports, Vol 54, Iss 1, Pp 54-60 (2020)
JIMD Reports, Vol 54, Iss 1, Pp 54-60 (2020)
Background Infantile neuroaxonal dystrophy (INAD) is a rare, autosomal recessive disease due to defects in PLA2G6 and is associated with lipid peroxidation. RT001 is a di‐deuterated form of linoleic acid that protects lipids from oxidative damage.